Medicinal Products

Palexia retard 25 mg tablete s produljenim oslobađanjem

Name Palexia retard 25 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-411609269
Active Substance tapentadolklorid
Composition jedna tableta s produljenim oslobađanjem sadrži 25 mg tapentadola (u obliku tapentadolklorida)
Pharmaceutical Form tableta s produljenim oslobađanjem
Manufacturer Grünenthal GmbH, Aachen, Njemačka
Marketing Authorisation Holder Grünenthal GmbH, Zieglerstraße 6, Aachen, Njemačka
Marketing Authorisation Date 27.07.2015
MA Period of Validity unlimited
Classification Number UP/I-530-09/14-02/423
Registration Number 381-12-01/30-15-07
Prescription na recept
Type of prescription poseban recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code N02AX06
Medicinal product marketed in the Croatia Ne
SmPC download
PL download
Public Assessment Report download

Packaging

Back

For Patients and Public

For Health Care Professionals

For Industry Representatives